الثلاثاء 9 جمادى الأولى 1448هـ
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
تحقق من أن الموقع يستخدم بروتوكول HTTPS
مسجل لدى هيئة الحكومة الرقمية برقم :
| عنوان الدراسة | داعم الدراسة | حالة الدراسة | دواء الدراسة | مرحلة الدراسة | رقم بروتوكول الدراسة | موقع الدراسة |
|---|---|---|---|---|---|---|
| Real-World Evidence non-interventional prospective study for the effectiveness, tolerability and adherence of Asciminib after two previous TKIs in Patients with Chronic Myelogenous Leukemia in chronic phase (CML-CP) in Saudi Arabia. (ASC4REAL) | Novartis | Ongoing | Scemblix (Asciminib/ ABL001) | 4 | CABL001ASA | King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah), King Fahad Specialist Hospital (Dammam) |
| Boehringer Ingelheim | Ongoing | BI 1015550 | 3 | 1305-0031 | King Abdulaziz Medical City NG (Riyadh) | |
| ational, Registry of Patients with Anti-Aquaporin 4 Antibody-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated with Alexion Complement Component 5 (C5) Inhibitor Therapies (ALXN-C5IT) | Astrazeneca | Ongoing | Ultomiris (Ravulizumab) | 4 | ALX-NMO-50 | King Khalid University Hospital (Riyadh) ,King Abdulaziz Medical City NG (Jeddah) |
| A Phase 2/3 Randomized, Multicenter Study of Osivelotor Administered Orally to Participants with Sickle Cell Disease and an Open-Label Pharmacokinetics Study in Pediatric Participants with Sickle Cell Disease | Global Blood Therapeutics Inc, a wholly owned subsidiary of Pfizer. | Ongoing | Osivelotor | 2/3 | C5351004 (GBT021601) | 1. National Guard Health Affairs - Riyadh 2.Prince Mohammed bin Nasser Hospital - Jazan 3. King Saud University Medical city -Riyadh |
| Effect and safety of Semaglutide in diabetic kidney transplant recipients with obesity | AbbVie | Ongoing | Risankizumab | 3 | M23-784 | King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam) |
| INTERnational STudy Evaluating Lupus Outcomes after Anifrolumab Real-World Use (INTERSTELLAR): Multi-National, Observational, Prospective, Post-Launch, Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice | Astrazeneca | Ongoing | Anifrolumab | 4 | TMP-0010230 | Aseer Central Hospital (Abha), International Medical Center (Jeddah), King Khalid University Hospital (Riyadh) |
| Effect and safety of Semaglutide in diabetic kidney transplant recipients with obesity | King Faisal Specialist Hospital and Research Center (Riyadh) | Ongoing | Semaglutide | 3 | 2241130 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Survey assessing prospective patient’s short-term treatment satisfaction and Quality of Life in patients with Hidradenitis Suppurativa initiated on Cosentyx (Secukinumab) in routine clinical practice in Saudi Arabia | Novartis | Ongoing | Secukinumab | 4 | CAIN457MSA | King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah) |
| Comparing the effectiveness of buccal infiltration of different volumes of Articaine for extraction of mandibular posterior teeth- A randomized clinical trial. | Dental Clinic-collage of Dentistry-Qassim Unviersity | Ongoing | ARTICAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE | 4 | 6074514624 | Dental Clinic-collage of Dentistry-Qassim Unviersity (Al-Qassim) |
| A Randomized, Double-Blinded, Placebo-Controlled, Phase 3, Parallel-Group Design Study Evaluating the Efficacy and Safety of Efgartigimod IV in Adult Participants With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis | Argenx BV | Ongoing | Efgartigimod IV | 3 | ARGX-113-2308 | King Faisal Specialist Hospital and Research Center (Riyadh),King Abdulaziz Medical City NG (Riyadh) |
تاريخ آخر تحديث: 06/10/2026 بتمام الساعة 08:14 صباحا بتوقيت المملكة العربية السعودية
لم يتم تقديم أي تقييمات لهذه الصفحة بعد.
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.